Brokerages Set Surgery Partners, Inc. (NASDAQ:SGRY) PT at $36.63

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have earned an average rating of "Moderate Buy" from the nine analysts that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $34.75.

SGRY has been the subject of a number of analyst reports. Royal Bank of Canada reiterated an "outperform" rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Tuesday, March 25th. Benchmark reiterated a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Monday. Finally, Macquarie lowered their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research report on Tuesday, March 11th.

Insider Buying and Selling at Surgery Partners

In other Surgery Partners news, CEO Jason Eric Evans sold 26,520 shares of the stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.65, for a total value of $680,238.00. Following the completion of the transaction, the chief executive officer now directly owns 560,698 shares in the company, valued at approximately $14,381,903.70. This trade represents a 4.52 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO David T. Doherty sold 6,733 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the completion of the transaction, the chief financial officer now owns 150,868 shares of the company's stock, valued at $3,623,849.36. This represents a 4.27 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 106,622 shares of company stock worth $2,717,860. 2.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Surgery Partners

A number of hedge funds have recently made changes to their positions in SGRY. Geode Capital Management LLC raised its position in shares of Surgery Partners by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company's stock worth $60,117,000 after acquiring an additional 42,897 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Surgery Partners during the third quarter worth about $626,000. Franklin Resources Inc. raised its position in shares of Surgery Partners by 19.5% during the third quarter. Franklin Resources Inc. now owns 21,324 shares of the company's stock worth $677,000 after acquiring an additional 3,487 shares during the last quarter. Principal Financial Group Inc. bought a new position in shares of Surgery Partners during the third quarter worth about $1,469,000. Finally, JPMorgan Chase & Co. grew its stake in Surgery Partners by 3.0% during the third quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company's stock worth $6,107,000 after purchasing an additional 5,551 shares during the period.

Surgery Partners Stock Performance

SGRY stock traded up $0.60 during mid-day trading on Friday, hitting $21.11. 117,538 shares of the company were exchanged, compared to its average volume of 1,242,914. The business has a 50 day simple moving average of $23.33 and a 200-day simple moving average of $24.23. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The stock has a market capitalization of $2.69 billion, a PE ratio of -43.98, a price-to-earnings-growth ratio of 19.21 and a beta of 2.40. Surgery Partners has a 1-year low of $19.50 and a 1-year high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $864.40 million during the quarter, compared to the consensus estimate of $828.09 million. On average, equities analysts forecast that Surgery Partners will post 0.67 earnings per share for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.